Grants Awarded

LCH
All
  • All
  • HLH/FEL/FHL
  • LCH
  • Rare Histiocytic Disorders and Other Topics

Mapping and understanding the heterogeneity of Langerhans cell histiocytosis using single-cell analysis

Florent Ginhoux Singapore Immunology Network (SIgN) / A*STAR, Singapore

Read More

Developmental Hierarchy in LCH

Principal Investigator Caroline Hutter St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2018 Amount of Award…

Read More

Maintenance of the IT platform of the LCH-IV Treatment Protocol Study (LCH-IVTPS)

Principal Investigator Milen Minkov CCRI, St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2017 Amount of…

Read More

Innate T cells in Langerhan’s Cell Histiocytosis

Principal Investigator Stuart Berzins, Ph.D. Federation University Australia Ballarat, Victoria, Australia Date of Award December 2016 Amount…

Read More

The Interplay of NOTCH and MAPK Pathway in LCH

Principal Investigator Raphaela Schwentner, MSc, PhD Children’s Cancer Research Institute Vienna, Austria   Date of Award December…

Read More

LCH-IV Clinical Trial – Stratum I Patient Registration Reimbursement for North American Institutions

Principal Investigator Carlos Rodriguez-Galindo, MD St. Jude Children’s Research Hospital Memphis, Tennessee USA   Date of Award…

Read More

Novel Animal Model for LCH

Principal Investigator Sergio Lira, MD, PhD Icahn School of Medicine at Mount Sinai, New York, New York…

Read More

Exploring CD8+ T cell-LCH-cell Interactions in Langerhans cell histiocytosis: A Three Center Study

Principal Investigator Astrid van Halteren, PhD Leiden University Medical Center, Leiden, Netherlands Date of Award December 2014…

Read More

Unraveling the Pathophysiological Role of the BRAFV600E Mutation in Langerhans Cell Histiocytosis (LCH) and its Therapeutical Implications with Murine Models of High-Risk LCH

Principal Investigator Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai – New York, New…

Read More

Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol Study

Project Administrators Histiocyte Society Executive Board LCH Study Reference Center – Vienna, Austria Date of Award December…

Read More